United States Neurology Devices Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Csf Management, Interventional Neurology, Neurosurgical Products, Radiosurgery and Neurostimulation Devices, Equipment and Supplies

Product Code GMD04570
Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 341
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

United States Neurology Devices Medical Equipment Industry Report

Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Csf Management, Interventional Neurology, Neurosurgical Products, Radiosurgery and Neurostimulation Devices, Equipment and Supplies

This report is an essential source for in-depth information and data relating to United States neurology devices medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in United States

Scope

  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Neurology Devices
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel Data
      • 3.2.2 Healthcare Facilities Data
  • 4 Neurology Devices in United States
    • 4.1 Neurology Devices Overall Revenue (2000-2012)
    • 4.2 Neurology Devices Overall Volume (2000-2012)
    • 4.3 Neurology Devices Overall Company Share (2000-2012)
  • 5 CSF Management in United States
    • 5.1 CSF Management Category Revenue
      • 5.1.1 Hydrocephalus Shunts Overall Revenues (2000-2012)
      • 5.1.2 ICP Monitoring Devices Overall Revenues (2000-2012)
    • 5.2 CSF Management Overall Volume (2000-2012)
      • 5.2.1 Hydrocephalus Shunts Overall Volume (2000-2012)
      • 5.2.2 ICP Monitoring Devices Overall Volume (2000-2012)
    • 5.3 CSF Management Average Price (2000-2012)
      • 5.3.1 Hydrocephalus Shunts Average Price (2000-2012)
      • 5.3.2 ICP Monitoring Devices Average Price (2000-2012)
    • 5.4 CSF Management Distribution Share (2005-2006)
    • 5.5 CSF Management Company Share (2005-2006)
  • 6 Radiosurgery in United States
    • 6.1 Radiosurgery Overall Revenue (2000-2012)
    • 6.2 Radiosurgery Overall Volume (2000-2012)
      • 6.2.1 CyberKnife Radiosurgery Overall Volume (2000-2012)
      • 6.2.2 GammaKnife Radiosurgery Overall Volume (2007-2012)
    • 6.3 Radiosurgery Average Price (2000-2012)
      • 6.3.1 CyberKnife Radio surgery Average Price (2000-2012)
      • 6.3.2 GammaKnife Radio surgery Average Price (2000-2012)
    • 6.4 Radiosurgery Distribution Share (2005-2006)
    • 6.5 Radio Surgery Company Share (2006-2006)
  • 7 Neurostimulation Devices in India
    • 7.1 Neurostimulation Devices Overall Revenue (2000-2012)
      • 7.1.1 Spinal Cord Stimulators Overall Revenues (2000-2012)
      • 7.1.2 Deep Brain Stimulator Overall Revenues (2000-2012)
      • 7.1.3 Vagus Nerve Stimulators Overall Revenues (2000-2012)
    • 7.2 Neurostimulation Devices Overall Volume (2000-2012)
      • 7.2.1 Spinal Cord Stimulator Overall Volume (2000-2012)
      • 7.2.2 Deep Brain Stimulator Overall Volume (2000-2012)
      • 7.2.3 Vagus Nerve Stimulators Overall Volume (2000-2012)
    • 7.3 Neurostimulation Devices Average Price (2000-2012)
      • 7.3.1 Spinal Cord Stimulator Average Price (2000-2012)
      • 7.3.2 Deep Brain Stimulator Average Price (2000-2012)
      • 7.3.3 Vagus Nerve Stimulator Average Price (2000-2012)
    • 7.4 Neurostimulation Devices Distribution Share (2005-2006)
    • 7.5 Neurostimulation Devices Company Share (2005-2006)
  • 8 Interventional Neurology in United States
    • 8.1 Interventional Neurology Overall Revenue (2000-2012)
      • 8.1.1 Navigational System Overall Revenues (2000-2012)
      • 8.1.2 Embolic System Overall Revenues (2000-2012)
      • 8.1.3 Aneurism Clips Overall Revenues (2000-2012)
    • 8.2 Interventional Neurology Overall Volume (2000-2012)
      • 8.2.1 Embolic System Overall Volume (2000-2012)
      • 8.2.2 Navigational System Overall Volume (2000-2012)
      • 8.2.3 Aneurism Clips Overall Volume (2000-2012)
    • 8.3 Interventional Neurology Average Price (2000-2012)
      • 8.3.1 Aneurism Clips Average Price (2000-2012)
      • 8.3.2 Embolic System Coils Average Price (2000-2012)
      • 8.3.3 Navigational System Average Price (2000-2012)
    • 8.4 Interventional Neurology Distribution Share (2005-2006)
    • 8.5 Interventional Neurology Company Share (2005-2012)
  • 9 Neuroendoscopes in United States
    • 9.1 Neuroendoscopes Overall Revenue (2000-2012)
    • 9.2 Neuroendoscopes Overall Volume (2000-2012)
    • 9.3 Neuroendoscopes Average Price (2000-2012)
    • 9.4 Neuroendoscopes Distribution Share (2005-2006)
    • 9.5 Neurosurgical Products Company Share (2005-2006)
  • 10 Elekta AB Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Treatment for Cancer and Brain disorder
      • 10.2.2 Products
      • 10.2.3 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
      • 10.3.2 Product Development
      • 10.3.3 Sales and Marketing
    • 10.4 SWOT Analysis
      • 10.4.1 Elekta AB Strengths
      • 10.4.2 Elekta AB Weaknesses
      • 10.4.3 Elekta AB Opportunities
      • 10.4.4 Elekta AB Threats
    • 10.5 Financial and Operational Review
    • 10.6 Locations And Subsidiaries
    • 10.7 Financial Deals Landscape
      • 10.7.1 Elekta Acquires CMS
      • 10.7.2 Elekta Acquires 3D Line Medical Systems
      • 10.7.3 Elekta Acquires 80% Equity Of Beijing Medical Equipment Institute
      • 10.7.4 Elekta Signs An Agreement With CIVCO Medical Solutions (formerly known as MEDTEC)
      • 10.7.5 Elekta Acquires Medical Intelligence Medizintechnik
      • 10.7.6 Elekta Completes $125 Million Senior Note Private Placement
      • 10.7.7 Elekta Acquires IMPAC Medical Systems
    • 10.8 Recent Developments
      • 10.8.1 Mar 10, 2008: Elekta To Deliver Brain Mapping Technology To Froedtert Hospital
    • 10.9 Elekta AB Pipeline Products
      • 10.9.1 Elekta Infinity
      • 10.9.2 Elekta VMAT
  • 11 Medtronic, Inc. Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Cardiac Surgery
      • 11.2.2 CRDM
      • 11.2.3 Diabetes
      • 11.2.4 ENT
      • 11.2.5 Neurological
      • 11.2.6 Physio-Control
      • 11.2.7 Spinal and Navigation
      • 11.2.8 Vascular
      • 11.2.9 Products
      • 11.2.10 History
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 Medtronic, Inc. Strengths
      • 11.4.2 Medtronic, Inc. Weaknesses
      • 11.4.3 Medtronic, Inc. Opportunities
      • 11.4.4 Medtronic, Inc. Threats
    • 11.5 Financial and Operational Review
    • 11.6 Locations And Subsidiaries
    • 11.7 Financial Deals Landscape
      • 11.7.1 Medtronic Enters Into Licensing Agreement With Arbor Surgical Technologies
      • 11.7.2 Arbor Surgical Technologies Secures $20 Million In Series C Financing
      • 11.7.3 REVA Medical Secures $42 Million In Financing
      • 11.7.4 CardioMEMS Secures $33 Million In Series E Financing
      • 11.7.5 Mitralign Secures $24 Million In Series C Financing
      • 11.7.6 Medtronic Acquires Kyphon
      • 11.7.7 Medtronic Acquires MRI Safety Patents From Biophan
      • 11.7.8 Bayer HealthCare Diabetes Care Signs An Agreement With Medtronic
      • 11.7.9 Alpine Acquires Neurodiagnostic Product Line From Medtronic
      • 11.7.10 Medtronic Signs An Agreement With Axon Systems
      • 11.7.11 Alpine Biomed Acquires Gastroenterology Diagnostics Product Line From Medtronic
      • 11.7.12 Innerpulse Announces Closing Of $50 Million Series C Round
    • 11.8 Recent Developments
      • 11.8.1 Apr 08, 2008: Medtronic Settles Lawsuit With Spectranetics
      • 11.8.2 Mar 19, 2008: FDA Calls Medtronic Drug Pump Warning Class I
      • 11.8.3 Mar 05, 2008: Recent Medical Device Recall Indicates Need For Patient Protections
      • 11.8.4 Mar 03, 2008: Medtronic Pays Akin Gump $140,000 To Lobby
      • 11.8.5 Mar 01, 2008: Medtronic And Other Device Makers Support Disclosure Of Payments To Doctors
      • 11.8.6 Feb 27, 2008: Medtronic Spends $1.7 Million On Lobbying In 2007
      • 11.8.7 Feb 27, 2008: Medtronic Announces First Human Use Of Its Bifurcation Stent
      • 11.8.8 Feb 26, 2008: Medtronic Says Sunshine Act Should Go Further
      • 11.8.9 Feb 22, 2008: Medtronic Elects New Board Member
      • 11.8.10 Feb 21, 2008: Medtronic Approves Cash Dividend
      • 11.8.11 Feb 20, 2008: US Supreme Court Shields Medical Device Manufacturers From Consumer Lawsuits
      • 11.8.12 Jan 28, 2008: Medtronic, Arbor Announce Exclusive Licensing Agreement
      • 11.8.13 Jan 10, 2008: Medtronic Foundation Announces New Grant Guidelines For Its HeartRescue Program
      • 11.8.14 Dec 21, 2007: Medtronic Resolves Marquis Defibrillator Lawsuits
      • 11.8.15 Dec 17, 2007: Medtronic And Weigao Announce Joint Venture In China
      • 11.8.16 Nov 15, 2007: Brower Piven Announces Class Action Lawsuit Against Medtronic
      • 11.8.17 Oct 19, 2007: Medtronic Approves Cash Dividend
      • 11.8.18 Aug 23, 2007: Medtronic Elects New President And CEO
      • 11.8.19 Aug 23, 2007: Medtronic Declares Quarterly Dividend
      • 11.8.20 Jun 22, 2007: Medtronic Elects New Directors
      • 11.8.21 Jun 22, 2007: Medtronic Declares Quarterly Dividend
      • 11.8.22 May 25, 2007: Biocompatibles Enters Agreement With Abbott
      • 11.8.23 May 07, 2007: Biosense Announce Strategic Alliance With Medtronic
      • 11.8.24 Jan 18, 2007: Medtronic Declares Quarterly Dividend
      • 11.8.25 Jan 18, 2007: Medtronic Elects New Board Member
      • 11.8.26 Jan 23, 2006: Edwards Lifesciences and Medtronic Settles Infringement Lawsuit
    • 11.9 Medtronic, Inc. Pipeline Products
      • 11.9.1 BRYAN Cervical Disc
      • 11.9.2 Endeavor Drug-Eluting Stent
      • 11.9.3 Medtronic Implantable Cardioverter Defibrillators
      • 11.9.4 EnRhythm MRI SureScan Pacing System
      • 11.9.5 DIAM Spinal Stabilization System
      • 11.9.6 Endurant Stent Graft System
      • 11.9.7 Talent Thoracic Stent Graft System
      • 11.9.8 PIVOTAL AAA
      • 11.9.9 Exponent RX Self-Expanding Carotid Stent
      • 11.9.10 GuardWire embolic protection system
      • 11.9.11 Deep Brain Stimulation (DBS) therapy
      • 11.9.12 Melody Transcatheter Pulmonary Valve
      • 11.9.13 Chronicle ICD
      • 11.9.14 Advantage Supra
      • 11.9.15 Pulmonic TCV
      • 11.9.16 Percutaneous AAA
      • 11.9.17 TGF Beta 1 Stent
      • 11.9.18 Cinched Mosaic
      • 11.9.19 LAA Occluder Band
      • 11.9.20 Prestige LP
      • 11.9.21 A-Mav
      • 11.9.22 Interceptor PLUS Coronary Filter System
      • 11.9.23 Sprint Quattro(Model 6944)
      • 11.9.24 Sprint Quattro(Model 6947)
      • 11.9.25 Valiant Thoracic Stent Graft
      • 11.9.26 Intercept Epilepsy Control System
      • 11.9.27 Bifurcation stent
      • 11.9.28 Single-coil Quattro lead
      • 11.9.29 OneTouch Glucose Meter
      • 11.9.30 Next Generation Insulin Pump
      • 11.9.31 Pre-filled Insulin Reservoirs
      • 11.9.32 Implantable Insulin Pump
  • 12 Accuray Incorporated Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Other
      • 12.2.2 Products
      • 12.2.3 Services
      • 12.2.4 Shared Ownership Program
      • 12.2.5 Products
      • 12.2.6 History
    • 12.3 Value Chain Analysis
      • 12.3.1 Manufacturing
      • 12.3.2 Product Development
      • 12.3.3 Sales and Marketing
    • 12.4 SWOT Analysis
      • 12.4.1 Accuray Incorporated Strengths
      • 12.4.2 Accuray Incorporated Weaknesses
      • 12.4.3 Accuray Incorporated Opportunities
      • 12.4.4 Accuray Incorporated Threats
    • 12.5 Financial and Operational Review
    • 12.6 Locations And Subsidiaries
    • 12.7 Financial Deals Landscape
      • 12.7.1 Alliance Imaging Acquires Six Radiosurgery CyberKnife Stereotactic Facilities From Accuray
      • 12.7.2 Accuray Enters Into A License Agreement With Cyberheart
      • 12.7.3 Accuray Signs Distribution And Co-Marketing Agreement With Siemens
      • 12.7.4 Accuray Incorporated Completes IPO
      • 12.7.5 Accuray Incorporated Acquires Certain Assets Of American Science and Engineering
    • 12.8 Recent Developments
      • 12.8.1 Feb 08, 2007: Accuray Announces Pricing Of Initial Public Offering
  • 13 Codman & Shurtleff, Inc. Company Profile
    • 13.1 Company Profile
      • 13.1.1 Products
    • 13.2 Locations And Subsidiaries
  • 14 Cyberonics, Inc. Company Profile
    • 14.1 Company Overview
    • 14.2 Business Overview
      • 14.2.1 Products
    • 14.3 Locations And Subsidiaries
    • 14.4 Financial Deals Landscape
      • 14.4.1 Cyberonics And Ethicon Endo-Surgery Enter Into License Agreement
      • 14.4.2 Boston Scientific Sells Its Stake In Cyberonics
      • 14.4.3 Carl Icahn Acquires 2% Stake In Cyberonics
      • 14.4.4 Cyberonics Completes Private Placement
      • 14.4.5 Advanced Neuromodulation Systems Sells Its Stake In Cyberonics
    • 14.5 Recent Developments
      • 14.5.1 Jul 09, 2007: Cyberonics Appoints New CFO
      • 14.5.2 Jun 11, 2007: Cyberonics Declares Fiscal 2007 Results
      • 14.5.3 Jun 11, 2007: Cyberonics Reports Fiscal Year 2007 Results
      • 14.5.4 May 01, 2007: Cyberonics Appoints New CEO
      • 14.5.5 May 01, 2007: Cyberonics Appoints New CEO
      • 14.5.6 Jan 29, 2007: Cyberonics Announces Board Changes
      • 14.5.7 Jan 29, 2007: Cyberonics Announces Board Changes
  • 15 Regulation System
    • 15.1 Medical Equipment Approval Process
      • 15.1.1 Pre-market Approval Process
      • 15.1.2 Intended use and Indications for use
      • 15.1.3 Predicate Device
      • 15.1.4 Safe and Effective
      • 15.1.5 Other Category Devices
      • 15.1.6 Post-Market Approval Process
      • 15.1.7 Compliance and Enforcement
      • 15.1.8 Registration Fee
      • 15.1.9 Approval Time
  • 16 Pricing and Reimbursement
    • 16.1 Government Policies
    • 16.2 Private Insurance
    • 16.3 Diagnosis Related Groups (DRG)
  • 17 Distribution Structure
    • 17.1 Distribution Structure
  • 18 APPENDIX
    • 18.1 Global Markets Direct Research Methodology
    • 18.2 Coverage
    • 18.3 Secondary Research
    • 18.4 Primary Research
    • 18.5 Models
    • 18.6 Forecasts
    • 18.7 Expert Panels
    • 18.8 Currency Conversion
    • 18.9 Contact Us
    • 18.10 Disclaimer
  • List of Tables
    • Table 1: United States Healthcare Expenditure, 2003-2010
    • Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003
    • Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003
    • Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003
    • Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004
    • Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004
    • Table 7: Total Number of Doctors in the United States, 2003-2010
    • Table 8: Number of Doctors by Specialty in the United States, 2003-2010
    • Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004
    • Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.)
    • Table 11: Total Hospitals in the United States, 2000-2004
    • Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004
    • Table 13: Number of Hospital Beds in the United States, 2000-2004
    • Table 14: Number of Hospital Beds by Range in the United States, 2000-2004
    • Table 15: Neurology Devices, United States, Overall Revenues ($ mn), 2000-2012
    • Table 16: Neurology Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 17: Neurology Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 18: Neurology Devices, United States, Category Revenues ($ mn), 2000-2012
    • Table 19: Neurology Devices, United States, Category Revenues ($ mn), Historic, 2000-2007
    • Table 20: Neurology Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 21: Neurology Devices, United States, Category Volume (Units), 2000-2012
    • Table 22: Neurology Devices, United States, Category Volume (Units), Historic, 2000-2007
    • Table 23: Neurology Devices, United States, Category Volume (Units), Forecast, 2007-2012
    • Table 24: Neurology Devices, United States, Company Share by Revenue ($ mn), 2005-2006
    • Table 25: CSF Management, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 26: CSF Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 27: CSF Management, United States, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 28: CSF Management, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 29: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 30: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 31: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 32: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 33: CSF Management, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 34: CSF Management, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 35: Hydrocephalus Shunts, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 36: Hydrocephalus Shunts, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 37: ICP Monitoring Devices, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 38: ICP Monitoring Devices, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 39: Hydrocephalus Shunts, United States, Average Price ($), Historic, 2000-2007
    • Table 40: Hydrocephalus Shunts, United States, Average Price ($), Forecast, 2007-2012
    • Table 41: ICP Monitoring Devices, United States, Average Price ($), Historic, 2000-2007
    • Table 42: ICP Monitoring Devices, United States, Average Price ($), Forecast, 2007-2012
    • Table 43: CSF Management, United States, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 44: CSF Management, United States, Company Share by Revenue ($ mn), 2005-2006
    • Table 45: Radiosurgery, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 46: Radiosurgery, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 47: Radiosurgery, United States, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 48: Radiosurgery, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 49: GammaKnife Radiosurgery, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 50: GammaKnife Radiosurgery, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 51: CyberKnife Radiosurgery, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 52: CyberKnife Radiosurgery, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 53: Radiosurgery, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 54: Radiosurgery, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 55: CyberKnife Radiosurgery, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 56: CyberKnife Radiosurgery, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 57: GammaKnife Radiosurgery, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 58: CyberKnife Radiosurgery, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 59: CyberKnife Radiosurgery, United States, Average Price ($), Historic, 2000-2007
    • Table 60: CyberKnife Radiosurgery, United States, Average Price ($), Forecast, 2007-2012
    • Table 61: GammaKnife Radio Surgery, United States, Average Price ($), Historic, 2000-2007
    • Table 62: GammaKnife Radio Surgery, United States, Average Price ($), Forecast, 2007-2012
    • Table 63: Radio Surgery, United States, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 64: Radio Surgery, United States, Company Share by Revenue ($ mn), 2005-2006
    • Table 65: Neurostimulation Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 66: Neurostimulation Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 67: Neurostimulation Devices, United States, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 68: Neurostimulation Devices, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 69: Spinal Cord Stimulators, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 70: Spinal Cord Stimulators, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 71: Deep Brain Stimulator, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 72: Deep Brain Stimulator, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 73: Vagus Nerve Stimulators, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 74: Vagus Nerve Stimulators, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 75: Neurostimulation Devices, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 76: Neurostimulation Devices, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 77: Spinal Cord Stimulators, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 78: Spinal Cord Stimulators, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 79: Deep Brain Stimulator, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 80: Deep Brain Stimulator, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 81: Vagus Nerve Stimulators, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 82: Vagus Nerve Stimulators, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 83: Spinal Cord Stimulators, United States, Average Price ($), Historic, 2000-2007
    • Table 84: Spinal Cord Stimulators, United States, Average Price ($), Forecast, 2007-2012
    • Table 85: Deep Brain Stimulators, United States, Average Price ($), Historic, 2000-2007
    • Table 86: Deep Brain Stimulators, United States, Average Price ($), Forecast, 2007-2012
    • Table 87: Vagus Nerve Stimulators, United States, Average Price ($), Historic, 2000-2007
    • Table 88: Vagus Nerve Stimulators, United States, Average Price ($), Forecast, 2007-2012
    • Table 89: Neurostimulation Devices, United States, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 90: Neurostimulation Devices, United States, Company Share by Revenue ($ mn), 2005-2006
    • Table 91: Interventional Neurology, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 92: Interventional Neurology, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 93: Interventional Neurology, United States, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 94: Interventional Neurology, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 95: Navigational System, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 96: Navigational System, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 97: Navigational System, United States, Revenues by Sub-segment($ mn), Historic, 2000-2007
    • Table 98: Navigational System, United States, Revenues by Sub-segment($ mn), Forecast, 2007-2012
    • Table 99: Navigational Catheters, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 100: Navigational Catheters, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 101: Guidewires, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 102: Guidewires, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 103: Embolic System, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 104: Embolic System, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 105: Embolic System, United States, Revenues by Sub-segment($ mn), Historic, 2000-2007
    • Table 106: Embolic System, United States, Revenues by Sub-segment($ mn), Forecast, 2007-2012
    • Table 107: Embolization Coils, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 108: Embolization Coils, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 109: Liquid Embolic Systems, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 110: Liquid Embolic Systems, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 111: Aneurysm Clips, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 112: Aneurysm Clips, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 113: Interventional Neurology, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 114: Interventional Neurology, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 115: Embolic System, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 116: Embolic System, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 117: Embolic System, United States, Volume by Subsegment (Units), Historic, 2000-2007
    • Table 118: Embolic System, United States, Volume by Subsegment (Units), Forecast, 2007-2012
    • Table 119: Liquid Embolic Systems, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 120: Liquid Embolic Systems, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 121: Embolization Coils, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 122: Embolization Coils, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 123: Navigational System, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 124: Navigational System, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 125: Navigational System, United States, Volume by Subsegment (Units), Historic, 2000-2007
    • Table 126: Navigational System, United States, Volume by Subsegment (Units), Forecast, 2007-2012
    • Table 127: Navigational Catheters, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 128: Navigational Catheters, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 129: Guidewires, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 130: Guidewires, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 131: Aneurysm Clips, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 132: Aneurysm Clips, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 133: Aneurysm Clips, United States, Average Price ($), Historic, 2000-2007
    • Table 134: Aneurysm Clips, United States, Average Price ($), Forecast, 2007-2012
    • Table 135: Embolization Coils, United States, Average Price ($), Historic, 2000-2007
    • Table 136: Embolization Coils, United States, Average Price ($), Forecast, 2007-2012
    • Table 137: Liquid Embolic Systems, United States, Average Price ($), Historic, 2000-2007
    • Table 138: Liquid Embolic Systems, United States, Average Price ($), Forecast, 2007-2012
    • Table 139: Navigational Catheters, United States, Average Price ($), Historic, 2000-2012
    • Table 140: Navigational Catheters, United States, Average Price ($), Forecast, 2007-2012
    • Table 141: Guidewires, United States, Average Price ($), Historic, 2000-2007
    • Table 142: Guidewires, United States, Average Price ($), Forecast, 2007-2012
    • Table 143: Interventional Neurology, United States, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 144: Interventional Neurology, United States, Company Share by Revenue ($ mn), 2005-2006
    • Table 145: Neuroendoscopes, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 146: Neuroendoscopes, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 147: Neuroendoscopes, United States, Overall Volume (Units), Historic, 2000-2007
    • Table 148: Neuroendoscopes, United States, Overall Volume (Units), Forecast, 2007-2012
    • Table 149: Neuroendoscopes, United States, Average Price ($), Historic, 2000-2007
    • Table 150: Neuroendoscopes, United States, Average Price ($), Forecast, 2007-2012
    • Table 151: Neuroendoscopes, United States, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 152: Neuroendoscopes, United States, Company Share by Revenue ($ mn), 2005-2006
    • Table 153: Elekta AB, SWOT Analysis, 2007
    • Table 154: Elekta AB, Financial Statements, SEK Million, 2003-2007
    • Table 155: Elekta AB, Financial Ratios, SEK Million, 2003-2007
    • Table 156: Elekta AB, Other Locations
    • Table 157: Elekta AB, Other Locations,(Cont.)
    • Table 158: Elekta AB, Subsidiaries
    • Table 159: Medtronic, Inc., SWOT Analysis, 2007
    • Table 160: Medtronic, Inc., Financial Statements, USD Million, 2003-2007
    • Table 161: Medtronic, Inc., Financial Ratios, USD Million, 2003-2007
    • Table 162: Medtronic, Inc., Other Locations
    • Table 163: Medtronic, Inc., Subsidiaries
    • Table 164: Accuray Incorporated, SWOT Analysis, 2007
    • Table 165: Accuray Incorporated, Financial Statements, USD Thousand, 2003-2007
    • Table 166: Accuray Incorporated, Financial Ratios, USD Thousand, 2003-2007
    • Table 167: Accuray Incorporated, Other Locations
    • Table 168: Codman & Shurtleff, Inc., Other Locations
    • Table 169: Cyberonics, Inc., Subsidiaries
    • Table 170: Medical Equipment Registration Fee in United States, 2007
    • Table 171: Medical Device Approval Time in United States, 2004
    • Table 172: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • List of Figures
    • Figure 1: United States, Healthcare Expenditure by Source, 2003
    • Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007
    • Figure 3: Healthcare Expenses Segmentation by End User, 2003
    • Figure 4: Neurology Devices, United States, Overall Revenues ($ mn), 2000-2012
    • Figure 5: Neurology Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 6: Neurology Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 7: Neurology Devices, United States, Category Revenues ($ mn), 2000-2012
    • Figure 8: Neurology Devices, United States, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 9: Neurology Devices, United States, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 10: Neurology Devices, United States, Company Share (%), 2006
    • Figure 11: CSF Management, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 12: CSF Management, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 13: CSF Management, United States, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 14: CSF Management, United States, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 15: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 16: Hydrocephalus Shunts, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 17: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 18: ICP Monitoring Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 19: CSF Management, United States, Overall Volume (Units), Historic, 2000-2007
    • Figure 20: CSF Management, United States, Overall Volume (Units), Forecast, 2007-2012
    • Figure 21: Hydrocephalus Shunts, United States, Overall Volume (Units), Historic, 2000-2007
    • Figure 22: Hydrocephalus Shunts, United States, Overall Volume (Units), Forecast, 2007-2012
    • Figure 23: ICP Monitoring Devices, United States, Overall Volume (Units), Historic, 2000-2007
    • Figure 24: ICP Monitoring Devices, United States, Overall Volume (Units), Forecast, 2007-2012
    • Figure 25: Hydrocephalus Shunts, United States, Average Price ($), Historic, 2000-2007
    • Figure 26: Hydrocephalus Shunts, United States, Average Price ($), Forecast, 2007-2012
    • Figure 27: ICP Monitoring Devices, United States